(Q34193337)

31 July 2017

1 reference

title

Vascular and metabolic dysfunction in Alzheimer's disease: a review (English)

1 reference

31 July 2017

0 references

Ian V J Murray

1

1 reference

31 July 2017

Joseph F Proza

series ordinal

2

1 reference

31 July 2017

Farida Sohrabji

series ordinal

3

1 reference

31 July 2017

John M Lawler

series ordinal

4

1 reference

31 July 2017

language of work or name

1 reference

16 June 2011

1 reference

Experimental Biology and Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

236

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

772-782

1 reference

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Indices of metabolic dysfunction and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cerebral microvascular pathology in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

A metabolic and functional overview of brain aging linked to neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Impaired brain microcirculation may trigger Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

An amyloid-notch hypothesis for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Neurovascular regulation in the normal brain and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Threats to the mind: aging, amyloid, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Insulin and neurodegenerative disease: shared and specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

New therapeutic targets in the neurovascular pathway in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer's disease: effects of β-amyloid on mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Promotion of oxidative lipid membrane damage by amyloid beta proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

NOX activity is increased in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

NADPH oxidases: molecular understanding finally reaching the clinical level?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Activation of NADPH oxidase in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer disease and cerebrovascular pathology: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

A diagnostic dilemma: is "Alzheimer's dementia" Alzheimer's disease, vascular dementia, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Increased beta-secretase activity and expression in rats following transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Preventing Alzheimer's disease : separating fact from fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer's disease: the cholesterol connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer's disease: brain expression of a metabolic disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Link between heart disease, cholesterol, and Alzheimer's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cholesterol, statins and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Promising strategies for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Angiotensins in Alzheimer's disease - friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Ketone bodies as a therapeutic for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

A metabolic basis for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Conformational Abs recognizing a generic amyloid fibril epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Conformation-dependent anti-amyloid oligomer antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The coexistence and differentiation of late onset Huntington's disease and Alzheimer's disease. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mixed systemic amyloidosis in a patient receiving long term haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Seeding specificity in amyloid growth induced by heterologous fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The cerebral glucose-fatty acid cycle: evolutionary roots, regulation, and (patho)physiological importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Glucose metabolism and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Metabolic reconfiguration is a regulated response to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidative damage in Alzheimer's disease: the metabolic dimension

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer's disease and cholesterol: the fat connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

NADPH oxidases of the brain: distribution, regulation, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Ketones: Metabolism's Ugly Duckling

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Oxidative stress increases expression and activity of BACE in NT2 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

In vitro effect of quinolinic acid on energy metabolism in brain of young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Metabolic reprogramming, caloric restriction and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Metabolic links between diabetes and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

PPARs in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Peroxisome proliferator-activated receptor gamma enhances the activity of an insulin degrading enzyme-like metalloprotease for amyloid-beta clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Inhibition of hexokinase leads to neuroprotection against excitotoxicity in organotypic hippocampal slice culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

Complex I: inhibitors, inhibition and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.010355

21 January 2018

Identifiers

DOI

10.1258/EBM.2011.010355

1 reference

31 July 2017

1 reference